Abstract P3-07-03: Anti-tumor activity of a liposomal formulation of Eribulin compared with the same dose of Eribulin in patient-derived breast cancer xenografts

求助中 20 由 Angel 发布于 2026/8/31 20:19:08

DOI:10.1158/1538-7445.sabcs22-p3-07-03
作者：M. Tanioka,?T. Semba,?T. Shimoi,?Yuki Niwa,?K. Yonemori
文献类型：期刊论文
补充材料：只需要正文

American Association for Cancer Research (AACR)

Abstract： Backgrounds: A liposomal formulation of Eribulin, E7389-LF may allow increased access to tumor tissues and has been under development for breast cancer. In a phase 1, expansion cohort as

应助信息

等您来应助

上传文件

1天前

Book学术机器人

2026/8/31 20:19:08 未找到该文献，机器人已退出，请等待人工下载

2026/8/31 20:19:08 Book学术AI机器人收到请求，开始寻找文献

2026/8/31 20:19:08 已向机器人发送请求

1天前

Angel 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Association for Cancer Research (AACR)Abstract 4543: Characterization of the liposomal formulation of eribulin mesylate (E7389) in mice